Novel Fluorinated Derivatives of the Broad-Spectrum MMP Inhibitors <i>N</i>-Hydroxy-2(<i>R</i>)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as Potential Tools for the Molecular Imaging of Activated MMPs with PET
作者:Stefan Wagner、Hans-Jörg Breyholz、Marilyn P. Law、Andreas Faust、Carsten Höltke、Sandra Schröer、Günter Haufe、Bodo Levkau、Otmar Schober、Michael Schäfers、Klaus Kopka
DOI:10.1021/jm0708533
日期:2007.11.1
An approach to the in vivo imaging of locally upregulated and activated matrix metalloproteinases (MMPs) found in many pathological processes is offered by positron emission tomography (PET). Hence, appropriate PET radioligands for MMP imaging are required. Here, we describe the syntheses of novel fluorinated MMP inhibitors (MMPIs) based on lead structures of the broad-spectrum inhibitors N-hydrox
正电子发射断层扫描(PET)提供了一种在许多病理学过程中发现的局部上调和激活的基质金属蛋白酶(MMP)的体内成像方法。因此,需要用于MMP成像的合适的PET放射性配体。在这里,我们描述了基于广谱抑制剂N-hydroxy-2(R)-[[((4-甲氧基苯基)磺酰基](苄基)-氨基] -3的前导结构的新型氟化MMP抑制剂(MMPI)的合成-甲基-丁酰胺(CGS 25966)和N-羟基-2(R)-[[((4-甲氧基苯基)磺酰基](3-吡啶甲基)-氨基] -3-甲基-丁酰胺(CGS 27023A)。另外,合成了用于用正电子发射体18F进行放射性标记的量身定制的前体化合物。所有制备的异羟肟酸酯目标化合物对MMP-2,MMP-8,MMP-9和MMP-13均显示出较高的体外MMP抑制能力。作为结果,通过两种不同的方法重新合成了有前途的氟化异羟肟酸衍生物1f,使其具有18F标记的形式,从而产生了潜在的PET放射性配体[18F]